IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Wildcat Capital Management, LLC

Q2 2025 Holdings

Filed 2025-07-18 | 6 holdings | $168.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Frontier Group Hldgs Inc(ULCC)COM35909R108$101.9M28,061,35160.5%
RLX Technology Inc(RLX)SPONSORED ADS74969N103$39.9M18,046,19523.7%
Acuren Corp(TIC)COM00510N102$16.6M1,500,0009.8%
Urogen Pharma LTD(URGN)COMM96088105$6.8M495,6064.0%
Allogene Therapeutics Inc(ALLO)COM019770106$3.1M2,920,7871.9%
Silexion Therapeutics CorpSHS NEWG1281K122$91.9K113,4280.1%